A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer.
Chen
William C
WC
Department of Radiation Oncology, University Hospitals Case Medical Center, Cleveland, OH 44106, USA. janice.lyons@uhhospitals.org
Kim
Janice
J
Kim
Edward
E
Silverman
Paula
P
Overmoyer
Beth
B
Cooper
Brenda W
BW
Anthony
Sue
S
Shenk
Robert
R
Leeming
Rosemary
R
Hanks
Shelli H
SH
Lyons
Janice A
JA
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001940:Breast / Q000528:radiation effects; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D002248:Carbon Monoxide / Q000378:metabolism; D059248:Chemoradiotherapy / Q000379:methods*; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D019583:Dose Fractionation, Radiation; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D015182:Lymphatic Irradiation; D015412:Mastectomy, Segmental; D008875:Middle Aged; D009367:Neoplasm Staging; D017239:Paclitaxel / Q000008:administration & dosage; D011653:Pulmonary Diffusing Capacity; D011855:Radiodermatitis / Q000209:etiology
D002248:Carbon Monoxide; D004317:Doxorubicin; D003520:Cyclophosphamide; D017239:Paclitaxel